New Data from Phase 4 Trial of VTAMA® (tapinarof) Cream, 1
WEBOct 16, 2023 · On May 24, 2022, Dermavant announced the FDA approved VTAMA ® (tapinarof) cream, 1% for the treatment of adult plaque psoriasis. The approval made VTAMA cream the first non-steroidal topical novel chemical entity launched for psoriasis in the U.S. in more than 25 years.
Dermavant Announces Positive Results from Phase 4 Open-Label Trial of VTAMA
WEBDec 6, 2023 · The FDA approved VTAMA cream for the topical treatment of mild, moderate, and severe plaque psoriasis in May 2022. Dermavant is also developing VTAMA cream for the treatment of atopic dermatitis in adults and children as young as 2 years old and released positive topline results from its ADORING 1 and 2 …
Dermavant Reports Positive Results from ADORING 2 Trial of VTAMA …
WEBMar 15, 2023 · Dermavant Sciences announced positive results from ADORING 2, one of two double-blind Phase 3 studies to evaluate the efficacy and safety of topical VTAMA® cream.
FDA Approves Dermavant’s VTAMA® (tapinarof) cream, 1% for
WEBMay 24, 2022 · As the first and only approved drug in its class in the U.S., the FDA’s approval of VTAMA cream provides an effective new non-steroidal treatment option for millions of adults living with plaque...
Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis
WEBDec 8, 2021 · In a phase 2b dose-finding trial, tapinarof cream was efficacious in adults with plaque psoriasis. 9,10 Here, we present the results of PSOARING 1 and PSOARING 2, two identical phase 3 trials that...
Dermavant claims its first approval as FDA clears psoriasis drug
WEBMay 25, 2022 · Roivant group company Dermavant has made the transition to a commercial-stage company after getting FDA approval for Vtama, a drug for psoriasis that it claims could be a game-changer in the...
FDA Approves Non-Steroidal Psoriasis Treatment Called Vtama
WEBJul 22, 2022 · The FDA has approved a new topical once-a-day treatment for plaque psoriasis called Vtama. In clinical trials, 40% of patients had clear or almost clear skin with the drug compared to 6% of those given a placebo cream. Vtama is not a corticosteroid.
VTAMA (Tapinarof) Cream, 1% Shows Efficacy in Patients With ...
WEBOct 20, 2023 · VTAMA (tapinarof) Cream, 1% performed well in intertriginous plaque psoriasis (iPsO), according to new Phase 4 data presented at the 43rd Annual Fall Clinical Dermatology Conference in Las Vegas. This Phase 4 study expands the body of data for VTAMA cream in adult plaque psoriasis.
Organon to Acquire Dermavant including its Innovative …
WEB2 days ago · About VTAMA® (tapinarof) cream, 1% VTAMA cream is a non-steroidal once-daily topical treatment that works by activating aryl hydrocarbon receptors in the skin to reduce inflammation and normalize ...
FDA Approves Dermavant's Vtama for Psoriasis
WEBMay 24, 2022 · FDA has approved Vtama® (tapinarof) cream, 1%, an aryl hydrocarbon receptor agonist from Dermavant for the topical treatment of plaque psoriasis in adults. Vtama cream is the first and only FDA-approved steroid-free topical medication in its class.
Skip to content